Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. [electronic resource]
Producer: 20180508ISSN:- 2050-084X
- Androgen Antagonists -- pharmacology
- Animals
- Azepines
- Benzamides
- Cell Line, Tumor
- Chromatin Immunoprecipitation -- methods
- Clustered Regularly Interspaced Short Palindromic Repeats
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Regulation, Neoplastic
- Heterografts
- Humans
- Male
- Metabolism, Inborn Errors -- metabolism
- Mice
- Nitriles
- Phenylthiohydantoin -- analogs & derivatives
- Prostatic Neoplasms -- pathology
- Receptors, Androgen -- metabolism
- Receptors, Glucocorticoid -- deficiency
- Sequence Analysis
- Signal Transduction -- drug effects
- Triazoles
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.